Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review.

Omid MirmosayyebElham Moases GhaffaryMohammad S DehghanHamed GhoshouniSara BagheriehMahdi BarzegarVahid Shayegannejad

Published in: Journal of central nervous system disease (2023)

Our systematic review demonstrated that following COVID-19 infection, there is a rare possibility of contracting MOGAD. Moreover, there is no clear consensus on the susceptibility of MOGAD patients to severe COVID-19. However, obtaining deterministic results requires studies with a larger sample size.

Keyphrases

systematic review
coronavirus disease
sars cov
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
meta analyses
randomized controlled trial
case control